Related references
Note: Only part of the references are listed.Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients
Arnaud Beddok et al.
NEURO-ONCOLOGY (2023)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2021)
Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity
Vijay M. Ravindra et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2020)
Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report
Benjamin T. Himes et al.
JOURNAL OF NEUROSURGERY (2019)
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
Tareq A. Juratli et al.
CANCER (2019)
Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy
Elham Rostami et al.
ACTA NEUROCHIRURGICA (2017)
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K. Brastianos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
Simon J. B. Aylwin et al.
PITUITARY (2016)
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K. Brastianos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
A Cross-Sectional Cohort Study of Cerebrovascular Disease and Late Effects After Radiation Therapy for Craniopharyngioma
Andrea C. Lo et al.
PEDIATRIC BLOOD & CANCER (2016)
Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma
Brad J. Greenfield et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
Priscilla K. Brastianos et al.
NATURE GENETICS (2014)
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
G. V. Long et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pointwise confidence intervals for a survival distribution with small samples or heavy censoring
Michael P. Fay et al.
BIOSTATISTICS (2013)
Brainstem Ganglioglioma Successfully Treated With Vemurafenib
Sarah Rush et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
Paolo A. Ascierto et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series
Marc C. Chamberlain
JOURNAL OF NEURO-ONCOLOGY (2013)
Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
Angela J. Sievert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Sleep dysfunction in long term survivors of craniopharyngioma
Peter E. Manley et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
BRAF Inhibition in Refractory Hairy-Cell Leukemia
Sascha Dietrich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up
Hermann L. Mueller et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Management of recurrent craniopharyngioma
Simon V. Liubinas et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
BRAF targeted therapy changes the treatment paradigm in melanoma
Antoni Ribas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
N Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2005)
Long-term outcomes for surgically resected craniopharyngiomas
JM Duff et al.
NEUROSURGERY (2000)
Share Paper
